43 min
Ep 31: Mark Cuban on Disrupting PBMs, Staying Curious & Using AI to Avoid NBA Fines Vital Signs with Jacob Effron and Nikhil Krishnan
-
- Investing
Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI.
Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI.
43 min